חזרה לתוצאות החיפוש

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Advanced Solid Tumor · Melanoma · Head and Neck Cancer · Gastric Cancer · Ovarian Carcinoma · Cervical Cancer · Endometrial Cancer · Bladder Cancer · Esophageal Cancer · Pancreatic Carcinoma · Prostate Cancer · Non-small Cell Lung Cancer (NSCLC) · Lung Cancer · Breast Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • City of Hope, Duarte, California, United States

  • Yale Cancer Center, New Haven, Connecticut, United States

  • AdventHealth Medical Group Oncology Research at Celebration, Kissimmee, Florida, United States

  • University of Illinois Cancer Center, Chicago, Illinois, United States

  • Johns Hopkins University, Baltimore, Maryland, United States

  • Health Partners Frauenshuh Cancer Center, Saint Louis Park, Minnesota, United States

  • Health Partners Cancer Center at Regions Hospital, Saint Paul, Minnesota, United States

  • Washington University, School of Medicine, St Louis, Missouri, United States

  • Roswell Park Cancer Institute IDS, Buffalo, New York, United States

  • Memorial Sloan Kettering Hospital, New York, New York, United States

  • SCRI Oncology Partners, Nashville, Tennessee, United States

  • The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • Fred Hutchinson Cancer Center, Seattle, Washington, United States

  • Chris O'Brien Lifehouse, Camperdown, Australia

  • Icon Cancer Centre Chermside, Chermside, Australia

  • Monash Medical Centre Clayton, Clayton, Australia

  • Icon Cancer Centre Hobart, Hobart, Australia

  • Icon Cancer Centre Townsville, Hyde Park, Australia

  • Cliniques Universitaires Saint-Luc, Brussels, Belgium

  • UZA, Edegem, Belgium

  • Universitair Ziekenhuis Gent, Ghent, Belgium

  • Universitair Ziekenhuis Brussel, Jette, Belgium

  • UZ Leuven, Leuven, Belgium

  • Cross Cancer Institute, Edmonton, Alberta, Canada

  • Sunnybrook Research Institute, Toronto, Canada

  • Princess Margaret Cancer Centre, Toronto, Canada

  • BC Cancer - Vancouver, Vancouver, Canada

  • West China Hospital, Sichuan University, Chengdu, China

  • Sun Yat-sen University Cancer Center, Guangzhou, China

  • Chu Bordeaux, Bordeaux, France

  • Centre Georges Franăois Leclerc, Dijon, France

  • Hopital Claude Huriez - Chu Lille, Lille, France

  • Centre Léon Bérard, Lyon, France

  • Hăpital de La Timone, Marseille, France

  • Chu Nantes - Hătel Dieu, Nantes, France

  • Institut Claudius Regaud, Toulouse, France

  • ICL - Alexis Vautrin, Vandœuvre-lès-Nancy, France

  • Institut Gustave Roussy, Villejuif, France

  • Krankenhaus Nordwest GmbH, Frankfurt, Germany

  • Bacs-Kiskun Varmegyei Oktatokorhaz, Kecskemét, Hungary

  • Humanitas Gavazzeni, Bergamo, Italy

  • IRCCS Ospedale Policlinico San Martino, Genova, Italy

  • AOU Federico II - Oncologia Clinica, Naples, Italy

  • Centro Ricerche Cliniche di Verona s.r.l., Verona, Italy

  • Saitama Medical University International Medical Center, Hidaka, Japan

  • National Cancer Center Hospital East, Kashiwa-shi, Japan

    Contact: Study coordinator (See Central Contact)

  • NHO Shikoku Cancer Center, Matsuyama, Japan

    Contact: Study coordinator (See Central Contact)

  • Shizuoka Cancer Center, Nagaizumi-cho, Japan

    Contact: Study coordinator (See Central Contact)

  • Aichi Cancer Center Hospital, Nagoya, Japan

  • Kindai University Hospital, Osakasayama-shi, Japan

    Contact: Study coordinator (See Central Contact)

  • National Cancer Center Hospital, Tokyo, Japan

  • Cancer Institute Hospital of JFCR, Tokyo, Japan

  • Yokohama City University Medical Center, Yokohama, Japan

  • Amsterdam UMC locatie Vumc, Amsterdam, Netherlands

  • Universitair Medisch Centrum Groningen, Groningen, Netherlands

  • Leids Universitair Medisch Centrum, Leiden, Netherlands

  • Maastricht University Medical Center, Maastricht, Netherlands

  • Radboud University Medical Center, Nijmegen, Netherlands

  • Akershus universitetssykehus, Lørenskog, Norway

  • Haukeland universitetssjukehus, Lørenskog, Norway

  • Oslo Universitetssykehus HF, Radiumhospitalet, Oslo, Norway

  • Cha Bundang Medical Center, Cha University, Seongnam, South Korea

  • Seoul National University Bundang Hospital, Seongnam, South Korea

  • Seoul National University Hospital, Seoul, South Korea

  • Severance Hospital, Yonsei University Health System, Seoul, South Korea

  • Asan Medical Center, Seoul, South Korea

  • Samsung Medical Center, Seoul, South Korea

  • Hospital Universitari Vall D'Hebron, Barcelona, Spain

  • Hospital Clinic de Barcelona, Barcelona, Spain

  • Hospital de La Santa Creu I Sant Pau, Barcelona, Spain

  • Hospital General Universitario Gregorio Marañon, Madrid, Spain

  • Hospital Universitario Ramon Y Cajal, Madrid, Spain

  • Hospital Universitario 12 de Octubre, Madrid, Spain

  • HOSPITAL REGIONAL UNIVERSITARIO de MALAGA AVDA., Málaga, Spain

  • Hospital Universitario Virgen Macarena, Seville, Spain

  • Hospital Clinico Universitario de Valencia, Valencia, Spain

  • Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan

  • National Cheng Kung University Hospital, Tainan, Taiwan

  • National Taiwan University Hospital, Taipei, Taiwan

  • Taipei Veterans General Hospital, Taipei, Taiwan

    Contact: Study coordinator (See Central Contact)

  • Chang Gung Memorial Hospital, Taoyuan, Taiwan

  • University Hospital Coventry, Coventry, United Kingdom

  • Barts Hospital, London, United Kingdom

  • Royal Free Hospital, London, United Kingdom

  • Nottingham City Hospital Campus, Nottingham, United Kingdom

מובילי המחקר

  • Global Clinical Leader

    Study Director

    Daiichi Sankyo

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)